Back to mobile site

Truist Securities Reiterates Buy Rating on Solid Biosciences (SLDB)

May 16, 2025 10:52 AM EDT Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $16.00 price target on Solid Biosciences (NASDAQ: SLDB).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login